BronwenEShawMD

PubMed

• Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomes.
  Stephen R Spellman, Rodney Sparapani, Martin Maiers, Bronwen E Shaw, Purushottam Laud
  Blood Advances. 2024-12-10
• Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.
  Brian C Shaffer, Mahasweta Gooptu, Todd DeFor, Stephen R Spellman, Heather E Stefanski
  Journal of Clinical Oncology. 2024-11-06
• 4 citations
  Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.
  Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor, Martin Maiers, Javier Bolaños-Meade
  Journal of Clinical Oncology. 2024-10-01

Journal Articles

• Current Use of Biosimilar G-CSF for Haematopoietic Stem Cell Mobilisation  
  Bronwen Shaw, MD, Nature
• Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
  Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
• Motives for Joining an Unrelated HSC Donor Registry: Description, Categorization, and Association with Donor Availability  
  Bronwen Shaw, MD, Nature
• Patient-Reported Outcomes and Health Status Associated with Chronic Graft-Versus-Host Disease  
  Bronwen Shaw, MD, Haematologica
• Join now to see all

Abstracts/Posters

• Building a National CML Registry
  Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the...
  Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor (CAR)-T Cell Therapy
  Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Lower Hematopoietic Progenitor Cell Counts and Yields at Subsequent Donations Is Influenced By a Shorter Inter-Donation Interval between the First and Subsequent Mobil...
  Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Risk Factors for the Development of Cutaneous Melanoma after Allogeneic Hematopoietic Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Impact of Myeloablative Total Body Irradiation Versus Chemotherapy on Late Effects and Survival Among Adolescent and Young Adult Survivors of Hematopoietic Cell Transp... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018